Bardy Diagnostics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 175

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $10.5M

Bardy Diagnostics General Information

Description

Developer of ambulatory cardiac monitoring devices designed to monitor and diagnose arrhythmia. The company's lightweight device is placed in the center of the chest, directly over the heart, for ECG and P-wave signal collection, enabling medical practitioners to track cardiac patients' heart rates remotely and improve decision-making.

Contact Information

Website
www.bardydx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 220 120th Avenue North East
  • Suite 100
  • Bellevue, WA 98005
  • United States
+1 (844)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Diagnostic Equipment
Parent Company
Corporate Office
  • 220 120th Avenue North East
  • Suite 100
  • Bellevue, WA 98005
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bardy Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 08-May-2025 $10.5M Completed Generating Revenue
10. Merger/Acquisition 02-Aug-2021 Completed Generating Revenue
9. Merger/Acquisition 15-Jan-2021 Cancelled Generating Revenue
8. Debt - PPP 27-Apr-2020 Completed Generating Revenue
7. Later Stage VC 30-Mar-2020 Cancelled Generating Revenue
6. Later Stage VC (Series B1) 14-Feb-2020 Completed Generating Revenue
5. Accelerator/Incubator 08-Aug-2019 Completed Generating Revenue
4. Accelerator/Incubator 01-Jun-2019 Completed Generating Revenue
3. Later Stage VC (Series B) 16-Apr-2019 $35.5M $70.9M Completed Generating Revenue
2. Grant 26-Sep-2018 $25K $35.4M Completed Startup
To view Bardy Diagnostics’s complete valuation and funding history, request access »

Bardy Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A 30,254,053 $0.001000 $0.07 $1.17 $1.17 1x $1.17 29.57%
To view Bardy Diagnostics’s complete cap table history, request access »

Bardy Diagnostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of ambulatory cardiac monitoring devices designed to monitor and diagnose arrhythmia. The company's lightweigh
Monitoring Equipment
Bellevue, WA
175 As of 2021

Mountain View, CA
 

Sunnyvale, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bardy Diagnostics Competitors (17)

One of Bardy Diagnostics’s 17 competitors is AliveCor, a Venture Capital-Backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AliveCor Venture Capital-Backed Mountain View, CA
MedM Accelerator/Incubator Backed Sunnyvale, CA
Huinno Venture Capital-Backed Seoul, South Korea
CardioDiagnostics Private Equity-Backed Campbell, CA
Medicomp Formerly PE-Backed Melbourne, FL
You’re viewing 5 of 17 competitors. Get the full list »

Bardy Diagnostics Patents

Bardy Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4838546-A1 Rose coil system for inductive charging Pending 05-May-2026
US-20260352026-A1 Rose coil system for inductive charging Pending 05-May-2025
EP-4763084-A1 Hydrogel containment solutions for thin-adhesive biomonitor Pending 23-Dec-2024
US-20260174371-A1 Hydrogel containment solutions for thin-adhesive biomonitor Pending 23-Dec-2024
US-20260122057-A1 Key management for medical devices Pending 25-Oct-2024 H04L63/083
To view Bardy Diagnostics’s complete patent history, request access »

Bardy Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bardy Diagnostics Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aperture Venture Partners Venture Capital Minority
Aphelion Capital Venture Capital Minority
Ascension Ventures Corporate Venture Capital Minority
HTA (Little Rock) Accelerator/Incubator Minority
Health Enterprise Partners Growth/Expansion Minority
You’re viewing 5 of 14 investors. Get the full list »

Bardy Diagnostics FAQs

  • When was Bardy Diagnostics founded?

    Bardy Diagnostics was founded in 2013.

  • Where is Bardy Diagnostics headquartered?

    Bardy Diagnostics is headquartered in Bellevue, WA.

  • What is the size of Bardy Diagnostics?

    Bardy Diagnostics has 175 total employees.

  • What industry is Bardy Diagnostics in?

    Bardy Diagnostics’s primary industry is Monitoring Equipment.

  • Is Bardy Diagnostics a private or public company?

    Bardy Diagnostics is a Private company.

  • What is Bardy Diagnostics’s current revenue?

    The current revenue for Bardy Diagnostics is .

  • How much funding has Bardy Diagnostics raised over time?

    Bardy Diagnostics has raised $10.5M.

  • Who are Bardy Diagnostics’s investors?

    Aperture Venture Partners, Aphelion Capital, Ascension Ventures, HTA (Little Rock), and Health Enterprise Partners are 5 of 14 investors who have invested in Bardy Diagnostics.

  • Who are Bardy Diagnostics’s competitors?

    AliveCor, MedM, Huinno, CardioDiagnostics, and Medicomp are some of the 17 competitors of Bardy Diagnostics.

  • When was Bardy Diagnostics acquired?

    Bardy Diagnostics was acquired on 08-May-2025.

  • Who acquired Bardy Diagnostics?

    Bardy Diagnostics was acquired by Hill-Rom Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process